A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]
Singh RP, Srivastava SK, Ehlers JP, et al. Clin Ophthalmol. 2015;9:1759–1766.On page 1763, Figure 4 has been amended. Read the original article
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-02-01
|
Series: | Clinical Ophthalmology |
Online Access: | https://www.dovepress.com/httpswwwdovepresscomcorrigendum-a-single-arm-investigator--peer-reviewed-article-OPTH |
id |
doaj-239904354ae741d0b8a664e266ab236e |
---|---|
record_format |
Article |
spelling |
doaj-239904354ae741d0b8a664e266ab236e2020-11-24T21:11:20ZengDove Medical PressClinical Ophthalmology1177-54832017-02-01Volume 1130330431164A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]Singh RPSrivastava SKEhlers JPSilva FQBedi RSchachat APKaiser PKSingh RP, Srivastava SK, Ehlers JP, et al. Clin Ophthalmol. 2015;9:1759–1766.On page 1763, Figure 4 has been amended. Read the original articlehttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-a-single-arm-investigator--peer-reviewed-article-OPTH |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Singh RP Srivastava SK Ehlers JP Silva FQ Bedi R Schachat AP Kaiser PK |
spellingShingle |
Singh RP Srivastava SK Ehlers JP Silva FQ Bedi R Schachat AP Kaiser PK A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] Clinical Ophthalmology |
author_facet |
Singh RP Srivastava SK Ehlers JP Silva FQ Bedi R Schachat AP Kaiser PK |
author_sort |
Singh RP |
title |
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] |
title_short |
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] |
title_full |
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] |
title_fullStr |
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] |
title_full_unstemmed |
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] |
title_sort |
single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (assess study): 12-month analysis [corrigendum] |
publisher |
Dove Medical Press |
series |
Clinical Ophthalmology |
issn |
1177-5483 |
publishDate |
2017-02-01 |
description |
Singh RP, Srivastava SK, Ehlers JP, et al. Clin Ophthalmol. 2015;9:1759–1766.On page 1763, Figure 4 has been amended. Read the original article |
url |
https://www.dovepress.com/httpswwwdovepresscomcorrigendum-a-single-arm-investigator--peer-reviewed-article-OPTH |
work_keys_str_mv |
AT singhrp asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT srivastavask asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT ehlersjp asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT silvafq asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT bedir asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT schachatap asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT kaiserpk asinglearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT singhrp singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT srivastavask singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT ehlersjp singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT silvafq singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT bedir singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT schachatap singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum AT kaiserpk singlearminvestigatorinitiatedstudyoftheefficacysafetyandtolerabilityofintravitrealafliberceptinjectioninsubjectswithexudativeagerelatedmaculardegenerationpreviouslytreatedwithranibizumaborbevacizumabassessstudy12monthanalysiscorrigendum |
_version_ |
1716753746488197120 |